New Research Supports CellQuest™ Formula’s Role in Treating Certain Cancers

Share Article

Research conducted at the H. Lee Moffitt Cancer Center & Research Institute indicates that an extract of the musaceas plant, the basis for the patented formula manufactured by CellQuest, Inc. may play a role in the prevention and treatment of cancer.

CLEARWATER, FL (PRWEB) August 4, 2003 – Research conducted at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fla. indicates that an extract of the musaceas (plantain and banana) plant may play a role in the prevention and treatment of cancer, lending credence to anecdotal evidence from patients and healthcare providers who have used or recommended the extract as an alternative therapy.

Previous studies have shown that musaceas extract contains high levels of polyphenols, substances that exhibit anti-carcinogenic activity. The extract is also the basis for the patented formula manufactured by the study’s sponsor, CellQuest, Inc. (http://www.cellquest.com), under the brand name CellQuest.

“Cancer kills more than 6 million people worldwide each year, making it the largest single cause of death. And while the current treatment strategies of radiation and chemotherapy kill some tumor cells, some others are resistant,” says CellQuest President Edward Ameen. “That realization is what prompted our search for natural alternatives, which ultimately led us to the musaceas plant. It’s gratifying that our research efforts are lending support to our theory.”

In the study, directed by Q. Ping Dou, Ph.D., lead investigator and an associate professor of biochemistry and molecular biology with Moffitt’s Drug Discovery program, the likely active ingredients of CellQuest -- hydrolyzed tannins -- were tested in varying concentrations on human leukemia Jurkat T cells, prostate cancer cells, breast cancer cells and normal, non-cancerous cells.

The typical strategy of many cancer treatments is to bring about “apoptosis,” or programmed cell death, in tumor cells. Certain proteins and enzymes such as proteasomes help tumor cells proliferate while simultaneously inhibiting the immune system’s natural ability to cause death in the diseased cells.

The Moffitt study bears out the hypothesis that CellQuest inhibits proteasomal activity in cancerous cells, halting their growth and inducing death of the tumor cells. The study also found that CellQuest had no effect on the body’s human natural killer cells, which aid the immune system in eradicating unwanted cell growth, or on normal healthy cells. This evidences CellQuest’s ability to selectively target tumor cells, in contrast to the typically non-discriminating action of most conventional therapies.

The results of Dou’s research didn’t surprise Florida resident Louis Sanchez, 26. In 1997, Sanchez was diagnosed with testicular cancer and, two years later, with lymphoma. In college at the time, Sanchez says he was hesitant to undergo chemotherapy treatments for the lymphoma. Nonetheless, he began preparing for the possibility that his education might need to wait while he underwent treatment. It was the Friday before his first treatment that an acquaintance told him about CellQuest.

“I didn’t want to quit school, and my friend’s faith in CellQuest was so strong that I decided to try it for one week before beginning chemo. When I went in for a scan at the end of that week, the tumor had shrunk,” says Sanchez, who is now in remission.

“I opted not to undergo chemo and continued to take CellQuest, but also decided to have surgery at six months for my own peace of mind. Afterward, the surgeon said it appeared that something had burned the tumor. When I told him about CellQuest, he wasn’t at all shocked. In fact, he shared his personal belief that the cure for cancer ultimately will be natural.”

Ameen concludes: “Louis’s story is just one of several we’ve received. And while we are obviously encouraged with the results of Dr. Dou’s research and the anecdotal reports, we also realize that more extensive research is key if we are to conclusively demonstrate the efficacy of the musaceas plant extract in boosting the body’s immune system fighting cancer naturally.”

About CellQuest, Inc.

Based in Clearwater, Fla., CellQuest, Inc. developed and now markets a patented formula based on the extract of the musaceas (plantain and banana) plant that scientific studies indicate has the ability to boost the body’s immune system. Called CellQuest™, the product is available for purchase as a liquid supplement or as a topical gel via the Company’s website, http://www.cellquest.com, or by calling, toll-free, (877) 565-5566.

###

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Elizabeth Roop
Rfb Communications Group, Inc.
813-259-0345
Email >